# Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder

> **NCT01764893** · PHASE4 · TERMINATED · sponsor: **Bay State Clinical Trials, Inc.** · enrollment: 8 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **OTHER:** PTNS plus solifenacin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01764893
- **Lead sponsor:** Bay State Clinical Trials, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-01
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Enrolling too slowly due to insurance plans no longer covering the cost of the Percutaneous Tibial Nerve Stimulation treatment.
- **Last updated:** 2014-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764893

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764893, "Use of Percutaneous Tibial Nerve Stimulation With Solifenacin or Placebo to Treat Refractory Overactive Bladder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01764893. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*